Global Chronic Kidney Disease (CKD) Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Global Chronic Kidney Disease (CKD) Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Discover the latest insights into the booming Chronic Kidney Disease (CKD) Drugs Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Chronic kidney disease (CKD) means your kidneys are damaged and can't filter blood the way they should. The main risk factors for developing kidney disease are diabetes, high blood pressure, heart disease, and a family history of kidney failure.
Based on the Chronic Kidney Disease (CKD) Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Chronic Kidney Disease (CKD) Drugs market covered in Chapter 5:
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Keryx Biopharmaceuticals, Inc.
Allergan plc.
Amgen Inc.
Sanofi S.A.
Kissei Pharmaceutical Co., Ltd
Johnson & Johnson
AbbVie, Inc.
AstraZeneca plc
Pfizer, Inc.
FibroGen Inc
Hoffmann-La Roche Ltd.
In Chapter 6, on the basis of types, the Chronic Kidney Disease (CKD) Drugs market from 2015 to 2025 is primarily split into:
Calcium Channel Blockers
Antihypertensive
Anemia Treatment Drugs
Antihyperlipidemic
Erythropoiesis-stimulating Agents (ESAs)
Swelling Treatment Drugs
Beta Blockers
Diuretics
Angiotensin-II Receptor Blockers
ACE Inhibitors
Other Drug Classes
In Chapter 7, on the basis of applications, the Chronic Kidney Disease (CKD) Drugs market from 2015 to 2025 covers:
Specialty Clinics
Hospitals
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Chronic Kidney Disease (CKD) Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 GlaxoSmithKline plc.
5.1.1 GlaxoSmithKline plc. Company Profile
5.1.2 GlaxoSmithKline plc. Business Overview
5.1.3 GlaxoSmithKline plc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 GlaxoSmithKline plc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.2 Teva Pharmaceutical Industries Ltd.
5.2.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.2.3 Teva Pharmaceutical Industries Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Teva Pharmaceutical Industries Ltd. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.3 Keryx Biopharmaceuticals, Inc.
5.3.1 Keryx Biopharmaceuticals, Inc. Company Profile
5.3.2 Keryx Biopharmaceuticals, Inc. Business Overview
5.3.3 Keryx Biopharmaceuticals, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Keryx Biopharmaceuticals, Inc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.4 Allergan plc.
5.4.1 Allergan plc. Company Profile
5.4.2 Allergan plc. Business Overview
5.4.3 Allergan plc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Allergan plc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.5 Amgen Inc.
5.5.1 Amgen Inc. Company Profile
5.5.2 Amgen Inc. Business Overview
5.5.3 Amgen Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Amgen Inc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.6 Sanofi S.A.
5.6.1 Sanofi S.A. Company Profile
5.6.2 Sanofi S.A. Business Overview
5.6.3 Sanofi S.A. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Sanofi S.A. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.7 Kissei Pharmaceutical Co., Ltd
5.7.1 Kissei Pharmaceutical Co., Ltd Company Profile
5.7.2 Kissei Pharmaceutical Co., Ltd Business Overview
5.7.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease (CKD) Drugs Products Introduction
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Company Profile
5.8.2 Johnson & Johnson Business Overview
5.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Products Introduction
5.9 AbbVie, Inc.
5.9.1 AbbVie, Inc. Company Profile
5.9.2 AbbVie, Inc. Business Overview
5.9.3 AbbVie, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 AbbVie, Inc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.10 AstraZeneca plc
5.10.1 AstraZeneca plc Company Profile
5.10.2 AstraZeneca plc Business Overview
5.10.3 AstraZeneca plc Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 AstraZeneca plc Chronic Kidney Disease (CKD) Drugs Products Introduction
5.11 Pfizer, Inc.
5.11.1 Pfizer, Inc. Company Profile
5.11.2 Pfizer, Inc. Business Overview
5.11.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products Introduction
5.12 FibroGen Inc
5.12.1 FibroGen Inc Company Profile
5.12.2 FibroGen Inc Business Overview
5.12.3 FibroGen Inc Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 FibroGen Inc Chronic Kidney Disease (CKD) Drugs Products Introduction
5.13 Hoffmann-La Roche Ltd.
5.13.1 Hoffmann-La Roche Ltd. Company Profile
5.13.2 Hoffmann-La Roche Ltd. Business Overview
5.13.3 Hoffmann-La Roche Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Hoffmann-La Roche Ltd. Chronic Kidney Disease (CKD) Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Chronic Kidney Disease (CKD) Drugs Price by Types (2015-2020)
6.2 Global Chronic Kidney Disease (CKD) Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Calcium Channel Blockers
6.3.2 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Antihypertensive
6.3.3 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Anemia Treatment Drugs
6.3.4 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Antihyperlipidemic
6.3.5 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Erythropoiesis-stimulating Agents (ESAs)
6.3.6 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Swelling Treatment Drugs
6.3.7 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Beta Blockers
6.3.8 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Diuretics
6.3.9 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Angiotensin-II Receptor Blockers
6.3.10 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of ACE Inhibitors
6.3.11 Global Chronic Kidney Disease (CKD) Drugs Sales, Price and Growth Rate of Other Drug Classes
6.4 Global Chronic Kidney Disease (CKD) Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Calcium Channel Blockers Market Revenue and Sales Forecast (2020-2025)
6.4.2 Antihypertensive Market Revenue and Sales Forecast (2020-2025)
6.4.3 Anemia Treatment Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.4 Antihyperlipidemic Market Revenue and Sales Forecast (2020-2025)
6.4.5 Erythropoiesis-stimulating Agents (ESAs) Market Revenue and Sales Forecast (2020-2025)
6.4.6 Swelling Treatment Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.7 Beta Blockers Market Revenue and Sales Forecast (2020-2025)
6.4.8 Diuretics Market Revenue and Sales Forecast (2020-2025)
6.4.9 Angiotensin-II Receptor Blockers Market Revenue and Sales Forecast (2020-2025)
6.4.10 ACE Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.11 Other Drug Classes Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Chronic Kidney Disease (CKD) Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Chronic Kidney Disease (CKD) Drugs Revenue, Sales and Growth Rate of Specialty Clinics (2015-2020)
7.3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue, Sales and Growth Rate of Hospitals (2015-2020)
7.4 Global Chronic Kidney Disease (CKD) Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Specialty Clinics Market Revenue and Sales Forecast (2020-2025)
7.4.2 Hospitals Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Regions (2015-2020)
8.2 Global Chronic Kidney Disease (CKD) Drugs Market Revenue by Regions (2015-2020)
8.3 Global Chronic Kidney Disease (CKD) Drugs Market Forecast by Regions (2020-2025)
9 North America Chronic Kidney Disease (CKD) Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Chronic Kidney Disease (CKD) Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Chronic Kidney Disease (CKD) Drugs Market Analysis by Country
9.6.1 U.S. Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
9.6.2 Canada Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
9.6.3 Mexico Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10 Europe Chronic Kidney Disease (CKD) Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Chronic Kidney Disease (CKD) Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Chronic Kidney Disease (CKD) Drugs Market Analysis by Country
10.6.1 Germany Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10.6.2 United Kingdom Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10.6.3 France Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10.6.4 Italy Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10.6.5 Spain Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
10.6.6 Russia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
11 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Analysis by Country
11.6.1 China Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
11.6.2 Japan Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
11.6.3 South Korea Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
11.6.4 Australia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
11.6.5 India Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
12 South America Chronic Kidney Disease (CKD) Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Chronic Kidney Disease (CKD) Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Chronic Kidney Disease (CKD) Drugs Market Analysis by Country
12.6.1 Brazil Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
12.6.2 Argentina Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
12.6.3 Columbia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
13 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Analysis by Country
13.6.1 UAE Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
13.6.2 Egypt Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
13.6.3 South Africa Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Chronic Kidney Disease (CKD) Drugs Market Size and Growth Rate 2015-2025
Table Chronic Kidney Disease (CKD) Drugs Key Market Segments
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Chronic Kidney Disease (CKD) Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table GlaxoSmithKline plc. Company Profile
Table GlaxoSmithKline plc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline plc. Production and Growth Rate
Figure GlaxoSmithKline plc. Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020
Table Keryx Biopharmaceuticals, Inc. Company Profile
Table Keryx Biopharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Keryx Biopharmaceuticals, Inc. Production and Growth Rate
Figure Keryx Biopharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Allergan plc. Company Profile
Table Allergan plc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Allergan plc. Production and Growth Rate
Figure Allergan plc. Market Revenue ($) Market Share 2015-2020
Table Amgen Inc. Company Profile
Table Amgen Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Inc. Production and Growth Rate
Figure Amgen Inc. Market Revenue ($) Market Share 2015-2020
Table Sanofi S.A. Company Profile
Table Sanofi S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Market Revenue ($) Market Share 2015-2020
Table Kissei Pharmaceutical Co., Ltd Company Profile
Table Kissei Pharmaceutical Co., Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Kissei Pharmaceutical Co., Ltd Production and Growth Rate
Figure Kissei Pharmaceutical Co., Ltd Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table AbbVie, Inc. Company Profile
Table AbbVie, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie, Inc. Production and Growth Rate
Figure AbbVie, Inc. Market Revenue ($) Market Share 2015-2020
Table AstraZeneca plc Company Profile
Table AstraZeneca plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AstraZeneca plc Production and Growth Rate
Figure AstraZeneca plc Market Revenue ($) Market Share 2015-2020
Table Pfizer, Inc. Company Profile
Table Pfizer, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Market Revenue ($) Market Share 2015-2020
Table FibroGen Inc Company Profile
Table FibroGen Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure FibroGen Inc Production and Growth Rate
Figure FibroGen Inc Market Revenue ($) Market Share 2015-2020
Table Hoffmann-La Roche Ltd. Company Profile
Table Hoffmann-La Roche Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hoffmann-La Roche Ltd. Production and Growth Rate
Figure Hoffmann-La Roche Ltd. Market Revenue ($) Market Share 2015-2020
Table Global Chronic Kidney Disease (CKD) Drugs Sales by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue ($) by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Price ($) by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Calcium Channel Blockers Sales and Growth Rate (2015-2020)
Figure Global Calcium Channel Blockers Price (2015-2020)
Figure Global Antihypertensive Sales and Growth Rate (2015-2020)
Figure Global Antihypertensive Price (2015-2020)
Figure Global Anemia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure Global Anemia Treatment Drugs Price (2015-2020)
Figure Global Antihyperlipidemic Sales and Growth Rate (2015-2020)
Figure Global Antihyperlipidemic Price (2015-2020)
Figure Global Erythropoiesis-stimulating Agents (ESAs) Sales and Growth Rate (2015-2020)
Figure Global Erythropoiesis-stimulating Agents (ESAs) Price (2015-2020)
Figure Global Swelling Treatment Drugs Sales and Growth Rate (2015-2020)
Figure Global Swelling Treatment Drugs Price (2015-2020)
Figure Global Beta Blockers Sales and Growth Rate (2015-2020)
Figure Global Beta Blockers Price (2015-2020)
Figure Global Diuretics Sales and Growth Rate (2015-2020)
Figure Global Diuretics Price (2015-2020)
Figure Global Angiotensin-II Receptor Blockers Sales and Growth Rate (2015-2020)
Figure Global Angiotensin-II Receptor Blockers Price (2015-2020)
Figure Global ACE Inhibitors Sales and Growth Rate (2015-2020)
Figure Global ACE Inhibitors Price (2015-2020)
Figure Global Other Drug Classes Sales and Growth Rate (2015-2020)
Figure Global Other Drug Classes Price (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Calcium Channel Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Calcium Channel Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Antihypertensive (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Antihypertensive (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Anemia Treatment Drugs (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Anemia Treatment Drugs (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Antihyperlipidemic (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Antihyperlipidemic (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Erythropoiesis-stimulating Agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Erythropoiesis-stimulating Agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Swelling Treatment Drugs (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Swelling Treatment Drugs (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Beta Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Beta Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Angiotensin-II Receptor Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Angiotensin-II Receptor Blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Other Drug Classes (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Other Drug Classes (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Sales by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue ($) by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Specialty Clinics Sales and Growth Rate (2015-2020)
Figure Global Specialty Clinics Price (2015-2020)
Figure Global Hospitals Sales and Growth Rate (2015-2020)
Figure Global Hospitals Price (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Market Revenue ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Sales by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions in 2019
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions in 2019
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Chronic Kidney Disease (CKD) Drugs Market Forecast Sales (2020-2025)
Figure North America Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drugs Market Forecast Sales (2020-2025)
Figure Europe Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure France Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure India Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drugs Market Forecast Sales (2020-2025)
Figure South America Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Chronic Kidney Disease (CKD) Drugs Market Sales and Growth Rate (2015-2020)
Research Methodology:
Chronic Kidney Disease (CKD) Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|